Navigation Links
Prescription Acne Treatment Manufacturing in the US Industry Market Research Report from IBISWorld Has Been Updated
Date:11/19/2013

Los Angeles, CA (PRWEB) November 19, 2013

Acne remains a common skin disorder experienced by teenagers and adolescents, affecting about 40 million to 50 million Americans, according to the American Academy of Dermatology. Due to increasing demand for acne treatments, the Prescription Acne Treatment Manufacturing industry has exhibited positive growth during the five years to 2013, and during the period, IBISWorld estimates that industry revenue has increased. Because acne-prone individuals consider treatment products a necessary expense, revenue continued to rise despite the recession, though growth did slow as consumers switched to more inexpensive products like over-the-counter (OTC) acne treatments. In addition, the increasing prevalence of adult-onset and persistent acne conditions has given rise to new, targeted products and an expanded consumer base, supporting revenue growth during the period. In 2013, with modest economic improvements giving way to greater disposable income growth, industry revenue is expected to increase.

According to IBISWorld Analyst Anna Son, “IBISWorld estimates that the top three players (Valeant Pharmaceuticals International Inc., Allergan Inc. and Galderma Laboratories LP) account for more than 20.0% of industry market share in 2013,” reflecting a low level of concentration. The remainder of the industry is characterized by a large number of small and medium-size businesses. Moreover, IBISWorld research indicates that companies employ only about 41 workers on average. In recent years, demand for prescription acne treatments has been mellow due to the rising use of OTC acne products, which are significantly less expensive and more easily accessible than their prescription counterparts. In recent years, more consumers have treated their acne with OTC products rather than seeing a specialist due to the difficulty of setting an appointment with a dermatologist, a general loss of health insurance coverage and a wide selection of OTC products. Nevertheless, in coming years, industry operators will be able to take advantage of new market opportunities stemming from the prevalence of adult onset acne.

“The outlook for the industry is promising,” says Son. During the five years to 2018, IBISWorld forecasts industry revenue to increase. The industry will benefit from improving economic conditions, as disposable income growth allows consumers to spend on higher-priced items. Furthermore, companies are expected to increasingly develop product lines with all-natural ingredients, given changing consumer preferences. Over the next five years, increasing private health insurance coverage will increasingly allow individuals access to prescription acne treatments, thus boosting industry demand. Still, the industry will continue to experience greater external competition from OTC acne products and laser treatments.

For more information, visit IBISWorld’s Prescription Acne Treatment Manufacturing in the US industry report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld industry Report Key Topics
Companies in the Prescription Acne Treatment Manufacturing industry are engaged in manufacturing prescription medications to control acne.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11342968.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Prescription Drug Addiction Rises Among Elderly—Novus Medical Detox Calls for Rx Drug Education
2. Tampa Drug Detox Introduces Updated Women’s Program for Rehabilitation from Prescription Drugs
3. The World Prescription Drug Market Report
4. New Best Drug Rehabilitation Video Features CEO Per Wickstrom Interviewing Dr. John R. Trotter II on Increasing Prescription Opiate Abuse
5. LOCKMED Develops New Product to Curb Prescription Drug Abuse
6. Diet Doc Hormone Diets & Weight Loss Plans Now Offers New Weight Loss Pills and Prescription Hormone Treatments to Enhance Low Fat Diets for Fast Fat Loss
7. Local Arizona Company Introduces New Patented Prescription Weight Loss Medicine
8. Diet Doc’s Prescription Hormone Diets & Weight Loss Plans Announces New Clean Eating Diet Plans to Slim the Waistline While Reducing the Risk for Colorectal Cancer
9. Diet Doc’s Prescription Hormone Diet Plans Now Offers More Affordable Diets, Making Weight Loss Inexpensive for Nearly Anyone
10. Diet Doc Hormone Diets & Weight Loss Plans Eliminate Belly Fat with Healthy Weight Loss Recipes and Diet Foods Enhanced by Prescription Hormone Treatments
11. Study: Access to health care increases prescription opioid availability and associated abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ... February 20, 2017 , ... A new ... women are called back for additional examinations without sacrificing cancer detection, according to ... 2011, the U.S. Food and Drug Administration approved digital breast tomosynthesis (DBT) for ...
(Date:2/20/2017)... (PRWEB) , ... February 21, 2017 , ... Nancy ... offering readers a way to “ Getting Over the Bump in the Road ” ... and lessons learned on how to cope with the ups and downs experienced by ...
(Date:2/20/2017)... ... ... Silverado today is pleased to announce that it has entered into a management ... Alexandria, Virginia. The new community is expected to open its doors in the first ... three-story community with underground parking – located on King Street –will serve 66 people ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... 213-8818 , Orbita, Inc., a leading provider of innovative software for connected home ... patient engagement and optimizing care journey management for home healthcare. , Built ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... a cloud-based self-service technology that runs on the Posiflex XT-series of touch screen ... during HIMSS17 in Orlando, Florida. The terminal provider Posiflex is helping ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Feb. 21, 2017 Cognitive Computing for ... is allowing a previously unattainable level of personalized ... this ability, it is anticipated that the Global ... Billion by 2022. The growth of the market ... computing platforms, rising installation of cognitive computing software ...
(Date:2/21/2017)... Feb. 21, 2017  /PR Newswire/ -- UBM Medica,s ... announce the launch of Modern Retina ( ... retina specialists. Built upon the success of ... on the latest innovations in the areas of retinal ... management. By meeting current informational needs and filling existing ...
(Date:2/21/2017)... Scientists From Two Companies to Accelerate Development ... ... STEER, creator of advanced materials platform technologies that effectively ... pharmaceuticals, food and nutraceuticals, biomaterials and biorefining, today announced a ... , a leading science & technology company, on ...
Breaking Medicine Technology: